Navigation Links
Sign•Arts Products to Spotlight Sign•Foam3® at ISA International Sign Expo, April 4-6, 2013 in Las Vegas
Date:3/28/2013

Tacoma, WA (PRWEB) March 28, 2013

Sign•Arts Products Corp. will showcase premier Sign•Foam3® products at the 2013 ISA International Sign Expo April 4-6 in Las Vegas, Nevada, the largest sign industry show in the world. Sign•Arts will be exhibiting at the Sign•Foam booth, #2437, in the Mandalay Bay Convention Center. This annual event brings together manufacturers, users and suppliers of on-premise signs and other visual communications systems.

Sign•Foam3® is the most reliable and enduring outdoor signage and modeling board available. This high-density, closed-cell polyurethane foam – also known as high-density urethane, or HDU – delivers exceptional versatility and outstanding value as a creative medium for dimensional sign making, environmental graphics, 3-D displays and model making. It is easily worked with the simplest hand tools as well as sophisticated CAD/CAM routers and CNC machines.

A dream medium for creative sign makers
“Hands down, Sign•Foam3® is the best HDU on the market. And now, it is even more affordable, offering sign makers the greatest opportunities for both creativity and profitability,” said Joe Scienski, chief executive officer of Sign•Arts Products. “The material is always consistent and predictable, with a smooth cell structure that supports intricate designs, crisp edges and very fine surface finishes. Not only does it bring out the sign maker’s artistry, it saves time and money compared to using wood or lower-quality HDUs.”

Because Sign•Foam3® is strong, durable, completely waterproof, and does not warp, bow, crack, rot or decompose, it is well-suited to any indoor or outdoor application. Made in the United States, it is nontoxic and free of VOCs and CFCs. It is also eco-friendly, with a minimum 16 percent green content. Whether carved, routed, sandblasted or machined, it is ideal wherever a uniform, grain-free, long-lasting and dimensionally stable ma
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Dr. Stephen Lazarus Continues to Recognize the Importance of Quality, Medical Skin Care and Products in Welcoming Licensed Paramedical Esthetician, Amye Smith
2. Bright Starts™ Baby Products Grabs 100,000 Facebook Fans
3. YourPleasurableSecrets.com, a leading retailer of Pipedream Products, Adult Toys & Novelties, is replenishing their lineup of adult movies Kay Parker has starred in.
4. Transvaginal Mesh Lawyer Applauds PBS Program Questioning FDA’s Approval of Pelvic Mesh Products
5. Ultimate Aquatics, announces the acquisition of SUP Products, the industry leader in U.S. Made Private Label Hybrid Molded Composite (HMC) Stand Up Paddle Boards (SUP) & Accessories.
6. Cearna Appoints Mark Chenoweth as Director of Sales for the Company’s Facial Plastic Surgery Recovery Products
7. Sejaa Skin Care Products Now Available through Ebay
8. AxoGen, Inc. to Highlight Products at the American Academy of Orthopedic Surgeons 2013 Meeting
9. HealthyChildren.org Offers Chance to Win Infant Health Products in Healthy Baby Sweepstakes
10. Corporate Whistle Blower Center Urges Physicians To Call them--If They Have Proof A Medical Device Company Was Knowingly Selling Defective Products
11. Nutralife Health Products Inc. Announces Launch of New Website for its Revolutionary Joint Supplement, JointRite
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... According to court documents, Donna Pirolli was a ... and underwent a procedure during which a duodenoscope was ... the duodenoscope allegedly had not been properly cleaned, Donna ... (CRE). , A lawsuit has been proceeding ... of Ms. Pirolli alleging that Lutheran General Hospital was ...
(Date:2/27/2015)... Legislation passed today by the House ... to help prevent inappropriate prescriptions in Medicare Part ... the Integrity of Medicare Act (PIMA), introduced by ... (R-TX) and Ranking Member Jim McDermott (D-WA), recognizes ... epidemic and implement the right policies, said the ...
(Date:2/27/2015)... Winter is here, and with it comes harsh ... snow and ice can be harmful on a dog’s paws. ... Puppy Store is ready to help pet owners know what ... the winter time. , Ice melts can lead to several ... Ingestion of ice melt products may cause depression, loss of ...
(Date:2/27/2015)... February 27, 2015 The Dawn Greene Hospice, ... Manning Walsh Home (MMW) on the Upper East Side, was ... of New York, His Eminence Timothy Michael Cardinal Dolan. , ... Board of Directors and a member of the ArchCare Board ... Sean William O’Brien, O.Carm, executive director of MMW, and Christina ...
(Date:2/27/2015)... 2015 FACE Skincare~Medical~Wellness, a multiaward-winning ... a unique combination to take fifteen years off ... is a new treatment introduced that is the ... indicated to improve lines and wrinkles on the ... who suffers from the stubborn vertical lines between ...
Breaking Medicine News(10 mins):Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:PCMA Statement on the ‘Protecting the Integrity of Medicare Act’ 2Health News:The Puppy Store Helps Dogs Prepare for Harsh Winter Conditions 2Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3Health News:Face Skincare Announces New Combination Therapy 2
... Philadelphians are expected to join the Lupus WHAT: Foundation of America for ... information and refreshments to support the need ... and information about signs and symptoms, diagnosis and tips to ... available at no charge to everyone., ...
... with secure transmission of patient data ... from hospital EMR to web-based PHR, ... (ICW), a global leader in eHealth technology,solutions and Memorial Hospital ... phase of Project Anchor, an initiative led by,Dr. Charles Eaton, ...
... and Optimize Reconstruction Surgery, TORONTO, May 8 ... of real-time imaging and image guidance systems for,use ... surgeons at Duke,University Hospital in Durham, North Carolina ... reconstructive surgical procedures. Since,beginning to use SPY near ...
... May 8 Biopure Corporation,(Nasdaq: BPUR ) ... has received new funding of approximately $3.4 million ... being granted,through the Department of Defense for a ... of Polytrauma Combat Casualties,with Brain Injury and Concomitant ...
... Scientific,Corporation (NYSE: BSX ) today announced U.S. ... family of pacemakers. ALTRUA is Boston,Scientific,s most advanced ... size and battery longevity. It is the first ... which the,heart beats too slowly -- usually less ...
... IDMI ) today reported financial results for the ... consolidated,results of IDM Pharma, Inc. and its subsidiary, IDM ... $2.4 million, and net loss was,$12.1 million or $0.48 ... non-cash charges of $4.7 million related to the increase ...
Cached Medicine News:Health News:5th Annual World Lupus Day Philadelphians Take Part In a Global Rally of Support 2Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 2Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 3Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 4Health News:Leading Plastic Surgeons at Duke Adopt SPY 2Health News:Leading Plastic Surgeons at Duke Adopt SPY 3Health News:Leading Plastic Surgeons at Duke Adopt SPY 4Health News:U.S. Navy Receives Funding for Further Development of Hemopure(R) 2Health News:U.S. Navy Receives Funding for Further Development of Hemopure(R) 3Health News:Boston Scientific Announces FDA Approval of New Family of Advanced Pacemakers 2Health News:Boston Scientific Announces FDA Approval of New Family of Advanced Pacemakers 3Health News:Boston Scientific Announces FDA Approval of New Family of Advanced Pacemakers 4Health News:IDM Pharma Reports First Quarter Financial Results 2Health News:IDM Pharma Reports First Quarter Financial Results 3Health News:IDM Pharma Reports First Quarter Financial Results 4Health News:IDM Pharma Reports First Quarter Financial Results 5Health News:IDM Pharma Reports First Quarter Financial Results 6Health News:IDM Pharma Reports First Quarter Financial Results 7Health News:IDM Pharma Reports First Quarter Financial Results 8
(Date:2/27/2015)... 2015  Pharmacyclics, Inc. (NASDAQ: PCYC ... published in the Proceedings of the National ... showed when ibrutinib (IMBRUVICA ® ) was combined ... of tumor growth was enhanced suggesting a greater ... cancers and solid tumors with the combination. IMBRUVICA ...
(Date:2/27/2015)... CARLSBAD, Calif., Feb. 27, 2015 Isis Pharmaceuticals, ... significantly outperformed both its pro forma net operating loss ... in a strong financial position.  Isis, significantly improved financial ... than $230 million in payments the Company received from ... for 2014 was a nearly 60% improvement over its ...
(Date:2/27/2015)... 2015   Synageva BioPharma Corp. (Synageva) ... developing therapeutic products for rare diseases, joins the ... Organisation for Rare Diseases™ (EURORDIS™), The Global Genes ... Rare Disease Day. On the last ... and other participants conduct special events to raise ...
Breaking Medicine Technology:In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6
... trial show those treated with,Prexige experienced significantly smaller ... Many patients with osteoarthritis also have high blood,pressure; ... risk[2],[3] , * Prexige approved in more than ... use in osteoarthritis patients , BASEL, Switzerland, June ...
... an AI Over Tamoxifen in,a Single Trial ... of the entire,population of a single trial has ... significantly improved by switching from,tamoxifen to anastrozole (Arimidex). ... published online in The,Journal of Clinical Oncology, confirms ...
Cached Medicine Technology:Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 6Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 2Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 3Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 4Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 5
... a broad selection of tip ... wide variety of ophthalmic procedures. ... packaged sterile, complete with a ... in the "off " position ...
... Accu-Temp Cauteries provide a broad ... cauterization in a wide variety ... use cautery is packaged sterile, ... to lock switch in the ...
... Cauteries provide a broad selection of ... wide variety of ophthalmic procedures. Each ... complete with a safety cap to ... position when not in use, and ...
... provide a broad selection of tip ... variety of ophthalmic procedures. Each single ... with a safety cap to lock ... when not in use, and carries ...
Medicine Products: